Corey K Goldman

Title: Corey K Goldman: Innovator in Gene Therapy

Introduction

Corey K Goldman is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of gene therapy, particularly in the inhibition of angiogenesis associated with various medical conditions.

Latest Patents

Goldman's most recent patent focuses on gene therapy for the inhibition of angiogenesis. This invention relates to methods that target solid tumor growth, tumor metastasis, inflammation, psoriasis, rheumatoid arthritis, hemangiomas, diabetic retinopathy, angiofibromas, and macular degeneration. The methodology involves gene transfer of a nucleotide sequence encoding a soluble form of a VEGF tyrosine kinase receptor to a mammalian host. This innovative approach aims to prevent the binding of VEGF to its receptors, thereby antagonizing the signals that promote tumor angiogenesis.

Career Highlights

Goldman is currently associated with Merck & Co., Inc., where he continues to advance his research in gene therapy. His work has the potential to impact the treatment of various diseases significantly.

Collaborations

He has collaborated with notable colleagues, including Kenneth A Thomas, Jr and Richard L Kendall, to further enhance the scope and application of his research.

Conclusion

Corey K Goldman is a pioneering inventor whose work in gene therapy is paving the way for innovative treatments in oncology and other medical fields. His contributions are vital in the ongoing fight against diseases that involve angiogenesis.